|
|
|
| Effect of Jianpi Yiwei Formula in the treatment of peptic ulcer with the syndrome of deficiency of spleen and stomach#br# |
| JIANG Yuping1 LIU Weifeng2 WEN Zhixi2 WU Shanshan2 DUAN Guijiao3 LYU Yanhang3 |
1.The Second Department of Internal Medicine, Mingxiu Branch of International Zhuang Medical Hospital Affiliated to Guangxi University of Chinese Medicine, Guangxi Zhuang Autonomous Region, Nanning 530001, China;
2.Department of Spleen-stomach Liver Disease, International Zhuang Medical Hospital Affiliated to Guangxi University of Chinese Medicine, Guangxi Zhuang Autonomous Region, Nanning 530200, China;
3.Graduate School, Guangxi University of Chinese Medicine, Guangxi Zhuang Autonomous Region, Nanning 530001, China |
|
|
|
Abstract Objective To explore the clinical effect of Jianpi Yiwei Formula in the treatment of peptic ulcer with the syndrome of deficiency of spleen and stomach. Methods A total of 90 patients of peptic ulcer with the syndrome of deficiency of spleen and stomach who were treated in Department of Spleen-stomach Liver Disease in the International Zhuang Medical Hospital Affiliated to Guangxi University of Chinese Medicine from September 2019 to February 2021 were divided into the control group and the treatment group by random number table method, 45 cases in each group. The control group was given Omeprazole Enteric-coated Capsules. The treatment group was treated with Jianpi Yiwei Formula on the basis of the control group. The clinical efficacy was observed for four weeks. The changes situation of pepsinogen (PG)Ⅰ, PGⅡ, and the PGⅠ / PGⅡ before and after treatment, the adverse events in the two groups were observed and recorded. Results The clinical effect of the treatment group was better than that in the control group (P < 0.05). After treatment, PGⅠ in the two groups were lower than those before treatment, and the treatment group was lower than that in the control group (P ＜ 0.05). After treatment, PG Ⅱ in the treatment group was lower than that before treatment, and PGⅡ in the treatment group was lower than that in the control group (P ＜ 0.05). There were no adverse reactions such as rash, nausea and vomiting, and needlesickness in the both groups. Conclusion Jianpi Yiwei Formula can effectively inhibit the expression of PGⅠ and PGⅡ, and improve the function of gastrointestinal peristalsis, and has definite effect of peptic ulcer with the syndrome of deficiency of spleen and stomach, there is no adverse reaction, it is worthy of reference, promotion, and application in clinic.
|
|
|
|
|
|
[1] 王松，肖丹，张小红，等.600例消化性溃疡患者幽门螺杆菌感染状况、耐药性及感染危险因素分析[J].中国病原生物学杂志，2019，14（7）：837-839.
[2] 夏芹芹，张小桑，张静薇.胃泌素-17、胃蛋白酶原及幽门螺杆菌感染率在不同胃部疾病中的表达差异[J].成都医学院学报，2020，15（6）：720-724.
[3] 赵靖涛，樊玲，张意，等.幽门螺杆菌感染根除后复发及其影响因素的研究[J].胃肠病学，2020，25（2）：104-108.
[4] 周钢.四联疗法根除幽门螺杆菌感染后复发情况及原因分析[J].中国药业，2020，29（12）：90-92.
[5] 陈建勇.黄芪建中汤加减联合针灸治疗脾胃虚寒型消化性溃疡疗效观察[J].中医临床研究，2019，11（23）：45-47.
[6] 陶艳丽，陈俊玲，陈禧.苓术健脾清胃汤联合针灸治疗消化性溃疡临床疗效及安全性评估[J].四川中医，2018，36（10）：106-109.
[7] 中国中西结合学会消化系统疾病专业委员会.消化性溃疡中西医结合诊疗共识意见[J].中国中西医结合消化杂志，2018，26（2）：12-120.
[8] 中华中医药学会脾胃病分会.消化性溃疡中医诊疗专家共识意见[J].中华中医药杂志，2017，32（9）：4089-4093.
[9] 刘伟锋，蒋玉萍，龙凤艳，等.健脾益胃方治疗慢性萎缩性胃炎30例临床观察[J].湖南中医杂志，2015，31（8）：4-6.
[10] 刘伟锋，蒋玉萍，龙凤艳，等.健脾益胃方治疗脾胃虚弱型慢性萎缩性胃炎疗效观察[J].光明中医，2015，30（11）：2334-2335.
[11] 刘伟锋，蒋玉萍，龙凤艳，等.健脾益胃方对30例慢性萎缩性胃炎胃黏膜病理形态学及EGF表达的影响[J].中国民族民间医药杂志，2015，24（5）：95-96.
[12] 黄波贞，石罗君，龙凤艳，等.健脾益胃方对消化性溃疡患者胃黏膜PGE2表达的影响[J].实用中医药杂志，2013， 29（6）：420-421.
[13] 张骏，胡熙曦，胡俊杰，等.基于网络药理学党参治疗胃溃疡的分子机制研究[J].中华中医药学刊，2021，39（8）：36-39.
[14] 邓桃妹，彭代银，俞年军，等.茯苓化学成分和药理作用研究进展及质量标志物的预测分析[J].中草药，2020， 51（10）：2703-2717.
[15] 顾思浩，孔维崧，张彤，等.白术的化学成分与药理作用及复方临床应用进展[J].中华中医药学刊，2020，38（1）：69-73.
[16] 蔺曼，王玉荣，翟新房，等.绞股蓝黄酮对氧化受损LLC-PK1细胞的保护作用[J].中华中药杂志，2019，44（6）：1193-1200.
[17] 袁冲，吴和珍，刘博，等.基于网络药理学半夏抗炎活性成分及作用机制研究[J].中华中医药学刊，2020，38（9）：150-153.
[18] 徐怡，陈途，陈明.丹参的化学成分及药理作用研究进展[J].海峡药学，2021，33（5）：45-48.
[19] 王阳，范潇晓，杨军，等.木香的萜类成分与药理成分研究进展[J].中华中药杂志，2020，45（24）：5917-5928.
[20] 张燕丽，田园，付起凤，等.白芍的化学成分和药理作用研究进展[J].中医药学报，2021，49（2）：104-109.
[21] 翟帆叶，陆婷婷.甘草活性成分及其成方防治胃溃疡及其药效学机制[J].河南中医，2019，39（6）：951-953.
[22] Pomytkina TE. The serum content of gastrin-17 and pepsinogen-1 in patients with duodenal ulcerative disease in occupational contact with nitrogenous compounds [J]. Klin Lab Diagn，2009（11）：16-19.
[23] 华勇.消化性溃疡患者血清胃蛋白酶原、胃泌素、Ⅰ型胶原氨基端前肽和肿瘤坏死因子-α的变化与幽门螺杆菌感染的关系[J].国际消化病杂志，2018，38（5）：348-351.
[24] 张亚庆.半夏泻心汤联合西药治疗脾胃虚弱证胃溃疡患者的临床效果[J].中国当代医药，2021，28（17）：186-189.
[25] 汪湃，冯世兵.PGⅠ、PGⅡ、ET、CGRP在Hp感染的消化性溃疡患者血清中的变化及其意义[J].四川医学，2019， 40（1）：87-90.
[26] 黄凤敏，谢里欣，刘燕鸣.血清PGⅠ、PGⅡ及G17水平诊断十二指肠溃疡的价值及其与Hp感染、病情的相关性[J].川北医学院学报，2021，36（3）：366-369. |
|
|
|
